Articles

  BioBuzz Regional | Greater Philadelphia | February 28, 2025

BioBuzz MediaBioBuzz Media
Mar 3, 2025 - 14:33
Mar 3, 2025 - 14:34
  BioBuzz Regional | Greater Philadelphia | February 28, 2025

The first signs of spring are here, and we hope you had a chance to enjoy the sunshine and refresh for the busy weeks ahead! This week, we have some exciting regional news to share, including an FDA Fast Track designation that could accelerate innovation, along with key mergers and acquisitions that hint at a promising future for some of our local companies. As always, we’ve handpicked the most important stories of the week to keep you informed and inspired.

Grab a coffee, get comfortable, and dive into this week’s top updates!

Bryan Kennedy + Owen Buzy

BioBuzz Networks | Greater Philadelphia

philadelphia@biobuzz.io

FINANCIAL

  • TELA Bio: Inducement Grants Under Nasdaq Listing Rule 5635 More

  • Baudax Bio: Asks for 5th Extension on Reorganization Plan Deadline More

  • Context Therapeutics: Inducement Grants Under Nasdaq Listing Rule 5635 More

  • CytoSorbents: Further Strengthens Balance Sheet With Exercise of Previously Announced Series A Right Warrants More

  • Rajant Health and Incite Health: Join Forces to Advance Precision Medicine and Remote Healthcare Solutions More

  • LAVA: Evaluation of Strategic Options More

  • Aclaris Therapeutics: Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update More

  • Certara: Fourth Quarter 2024 Financial Results More

  • Merck: $30M Grant Commitment From Delaware as State Looks to Entice Big Pharma Investment More

  • Teleflex: Will Acquire BIOTRONIK’s Vascular Intervention Business More

CLINICAL & COMMERCIAL

  • Sterotherapeutics: Initiation of a Phase 2 Clinical Trial for Patients With Cushing's Syndrome More

  • Synnovation Therapeutics: Second Program to Enter the Clinic - First Patient Dosed in Phase I Trial With SNV4818, a Potential Best-In-Class Pan-Mutant-Selective PI3Kα Inhibitor for the Treatment of Solid Tumors More

  • Pfizer: Shelves Beqvez, a Spark Therapeutics Developed Product More

  • Harmony Biosciences: Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs More

  • IMUNON: New Immunogenicity Data From Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19 More

  • Madrigal: New Two-Year Data From the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra (resmetirom) in Patients With Compensated MASH Cirrhosis More

  • Rockland Immunochemicals: Innovative Research to Advance Oligonucleotide Therapeutics Now Published in the Journal of Nucleic Acid Therapeutics More

  • Opthea: Completes Drug Product PPQ Campaign More

  • Sonnet BioTherapeutics: Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors More

  • Windtree: Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India More

  • Avobis Bio: Receives FDA Fast Track Designation for AVB-114 Implantable Cell Therapy for Crohn's Perianal Fistulas More

  • Virpax: Sees Positive Results in Human Study for Its Molecular Envelope Technology More

  • Ocugen: FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease More

WORKFORCE

  • Arbutus: Changes to Board of Directors and Appointment of Lindsay Androski as CEO More

  • Synnovation Therapeutics: Will Add More Than 40 New Jobs at Its Current Site in Wilmington-Area Innovation Space More

  • People on the Move: Matt Goddeeris Joins Every Cure as VP of Discovery More

  • Jonathan A. Epstein: named head of Perelman School of Medicine and Penn Health System More

JOBS

Ocugen (Malvern, PA)

Website | LinkedIn 

Ocugen, a fully integrated, patient-centric biotech company, is hiring for many roles including Head of Clinical Development and Vice President of Manufacturing & Supply.

Here are some other innovative companies in the region that are hiring:

  • Harmony Biosciences (Plymouth Meeting, PA) - A leading pharma company dedicated to innovative therapies for patients with rare neurological diseases. Check out jobs here>

    • Director, Medical Writing

    • Senior Director, Clinical Pharmacology

    • Senior Director, Business Development

  • Context Therapeutics (Philadelphia, PA) - A biopharma company advancing T cell engaging bispecific antibodies for solid tumors. Check out jobs here>

    • Head of Regulatory

    • Senior Director/VP, Data management

    • Director/Senior Director, Project Management

  • Iovance (Philadelphia, PA) - A commercial stage cell therapy company. Check out jobs here>

    • Project Manager

    • Supervisor, Aseptic Processing

    • Lead Quality Control Analyst

  • VintaBio (Philadelphia, PA) - Viral Vector Manufacturing. Check out jobs here>

    • Head of Analytical Development & Quality Control

    • Quality Assurance Document Control Training Manager

    • Office Manager

  • Century Therapeutics (Philadelphia, PA) - Century Therapeutics is an innovative biotechnology company that is building an industry leading allogeneic iPSC-derived cell therapy platform. Check out jobs here>

    • Scientific Director, Upstream Process

    • Senior Director, Clinical Development

    • CMMS Specialist

 

BUZZIN' EVENT

Find Out More on Our Next Event

BioInnovation Series Event Philadelphia's Push: Breaking Barriers in Rare Disease Research

Building off our successful BioInnovation Series launch event in February, we’re continuing the momentum with our next session—this time focused on Rare Disease Innovation. Philadelphia is home to groundbreaking advancements in rare disease research and therapeutic development, but how do we ensure these innovations lead to lasting impact, growth, and better patient outcomes?

Find Out More>
facebook
youtube
linkedin
BioBuzz, 101 West Dickman Street, Suite 1000, Baltimore, MD 21230, United States

You may unsubscribe or change your contact details at any time.

Tags:

Previous Article

Buzzin’ Brood: Student Spotlight - Fatima Mohammadi, FCC Biotech Bootcamp Graduate

Next Article

BioBuzz Philadelphia 2025 Workforce Champion of the Year Award: Honoring Finalis...

BioBuzz Media
BioBuzz Media BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.

Related Posts

How to Write an Effective Deviation that Gets to the True Root Cause

How to Write an Effective Deviation that Gets to the Tr...

Simone Ammons Apr 4, 2024

Is Philadelphia a Leading Advanced Therapies Hub? Experts Weigh in.

Is Philadelphia a Leading Advanced Therapies Hub? Exper...

BioBuzz Media Feb 13, 2025

Hello 2025! Philly Biotech’s Weekly Roundup Begins Here

Hello 2025! Philly Biotech’s Weekly Roundup Begins Here

BioBuzz Media Jan 10, 2025